Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - morphine hydrochloride dihydrocodeine hydrochloride papaverine hydrochloride - solution for injection - 15.4, 1.2, milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid - movapo pfs is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - morphine hydrochloride dihydrocodeine hydrochloride papaverine hydrochloride - solution for injection - 15.4, 1.2, milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 20 microgram(s) - drugs used in erectile dysfunction; alprostadil

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 10 microgram(s) - drugs used in erectile dysfunction; alprostadil

Ireland - English - HPRA (Health Products Regulatory Authority)

bracco uk limited - iopamidol - solution for injection - 340 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bracco imaging spa - iopamidol - solution for injection - 340 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; hydrochloric acid; water for injections - indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - alprostadil - powder and solvent for solution for injection - 20microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - alprostadil - powder and solvent for solution for injection - 10microgram